Cited by 26

Location as Destiny: Identifying Geospatial Disparities in Radiation Treatment Interruption by Neighborhood, Race, and Insurance

Wakefield, Daniel V., Carnell, Matthew, Dove, Austin P.H., Edmonston, Drucilla Y., Garner, Wesley B., Hubler, Adam, Makepeace, Lydia, Hanson, Ryan +8 more·2020·International Journal of Radiation Oncology*Biology*Physics

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijrobp.2020.03.016

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 52

  1. [1]Jaffray DA, Gospodarowicz MK. Radiation therapy for cancer. Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities. Third Edition. Washington, DC: The World Bank; 2015. p. 239– 248.
  2. [2]Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 2007; 68: 654– 661. 17467926
  3. [3]Giddings A. Treatment interruptions in radiation therapy for head-and-neck cancer: Rates and causes. J Med Imag Radiat Sci 2010; 41: 222– 229. 31051883
  4. [4]Khalil AA, Bentzen SM, Bernier J, Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Int J Radiat Oncol Biol Phys 2003; 55: 568– 575. 12573743
  5. [5]Matsuo K, Machida H, Ragab OM, Garcia-Sayre J, Yessaian AA, Roman LD. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer. J Surg Oncol 2017; 116: 482– 491. 28543055 PMC7523389
  6. [6]Ohri N, Rapkin BD, Guha C, Kalnicki S, Garg M. Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center. Int J Radiat Oncol Biol Phys 2016; 95: 563– 570. 27020104
  7. [7]Patel UA, Patadia MO, Holloway N, Rosen F. Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer. Laryngoscope 2009; 119: 528– 533. 19160390
  8. [8]Petereit DG, Sarkaria JN, Chappell R, The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1301– 1307. 7635769
  9. [9]Nogueira LM. Association between declared hurricane disasters and survival of patients with lung cancer undergoing radiation treatment. JAMA 2019; 322: 269– 271. 31310288 PMC6635902
  10. [10]Ohri N, Rapkin BD, Guha D, Predictors of radiation therapy noncompliance in an urban academic cancer center. Int J Radiat Oncol Biol Phys 2015; 91: 232– 238. 25835626
  11. [11]Cohen J, Harper A, Nichols EM, Rao GG, Mohindra P, Roque DM. Barriers to timely completion of radiation therapy in patients with cervical cancer in an urban tertiary care center. Cureus 2017; 9: e1681. 29152438 PMC5679772
  12. [12]Temkin SM, Fleming SA, Amrane S, Schluterman N, Terplan M. Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center. Gynecol Oncol 2015; 137: 497– 502. 25795262
  13. [13]Onega T, Duell EJ, Shi X, Wang D, Demidenko E, Goodman D. Geographic access to cancer care in the. U.S. Cancer 2008; 112: 909– 918. 18189295
  14. [14]Middelburg JG, Mast ME, de Kroon M, Timed get up and go test and geriatric 8 scores and the association with (chemo-)radiation therapy noncompliance and acute toxicity in elderly cancer patients. Int J Radiat Oncol Biol Phys 2017; 98: 843– 849. 28366575
  15. [15]Jaap K, Fluck M, Hunsinger M, Analyzing the impact of compliance with national guidelines for pancreatic cancer care using the National Cancer Database. J Gastrointest Surg 2018; 22: 1358– 1364. 29594911
  16. [16]Costas-Muniz R, Leng J, Aragones A, Association of socioeconomic and practical unmet needs with self-reported nonadherence to cancer treatment appointments in low-income Latino and Black cancer patients. Eth Heal 2016; 21: 118– 128. PMC4653085 25989483
  17. [17]Patel UA, Thakkar KH, Holloway N. Patient compliance to radiation for advanced head and neck cancer at a tertiary care county hospital. Laryngoscope 2008; 118: 428– 432. 18043491
  18. [18]Cronin KA, Lake AJ, Scott S, Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer 2018; 124: 2785– 2800. 29786848 PMC6033186
  19. [20]Holt JB. The topography of poverty in the United States: A spatial analysis using county-level data from the Community Health Status Indicators project. Prev Chron Dis 2007; 4: A111. PMC2099276 17875255
  20. [21]Shivayogi P. Vulnerable populations and methods for their safeguard. Perspect Clin Res 2013; 4: 53– 57. 23533983 PMC3601707
  21. [22]Waisel DB. Vulnerable populations in healthcare. Curr Opin Anaes 2013; 26: 186– 192. 23385323
  22. [23]Rebbeck TR. Defining priorities for reducing disparities in cancer mortality. Can Epidemiol Bio Prev 2016; 25: 570– 572. 27196088
  23. [24]Braveman PA, Kumanyika S, Fielding J, Health disparities and health equity: the issue is justice. Am J Public Health 2011; 101: S149– S155. 21551385 PMC3222512
  24. [25]Institute of Medicine. Toward health equity and patient-centeredness: Integrating health literacy, disparities reduction, and quality improvement: Workshop summary. Washington, DC: Institute of Medicine Workshop; 2009. 20662132
  25. [26]Singh GK. Socioeconomic and racial/ehnic disparities in cancer mortality, incidence, and survival in the United States, 1950–2014: Over six decades of changing patterns and widening inequalities. J Environ Pub Health 2017; 2819372. 28408935 PMC5376950
  26. [27]Fairchild ASW, Laurie F, Followill D. Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review. Int J Radiat Oncol Biol Phys 2013; 87: 246– 260. 23683829 PMC3749289
  27. [28]Cox JDPT, Asbell S, Russell AH, Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: Analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 1993; 27: 493– 498. 8226140
  28. [29]Yusuf MBGJ, Amsbaugh MJ, Woo S, Burton E. Survival impact of prolonged postoperative radiation therapy for patients with glioblastoma treated with combined-modality therapy. Neurooncol Pract 2019; 6: 112– 123. 31386043 PMC6656316
  29. [30]Machtay MHC, Komaki R, Sause WT, Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys 2005; 63: 667– 671. 15927409
  30. [32]Heukelom J, Hamming O, Bartelink H, Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE): A randomized controlled phase II trial for individualized treatment of head and neck cancer. BMC Cancer 2013; 13: 84. 23433435 PMC3599345
  31. [33]Armstrong RA. When to use a Bonferroni Correction. Ophth Physiol Optics 2014; 34: 502– 508. 24697967
  32. [34]Schootman M, Gomez SL, Henry KA, Geospatial approaches to cancer control and population sciences. Can Epidemiol Bio Prev 2017; 26: 472– 475. PMC5380532 28325736
  33. [35]Conroy SM, Shariff-Marco S, Koo J, Racial/ethnic differences in the impact of neighborhood social and built environment on breast cancer risk: The neighborhoods and breast cancer study. Can Epidemiol Bio Prev 2017; 26: 541– 552. PMC5380527 28196846
  34. [36]Fesinmeyer MD, Mehta V, Tock L, Blough D, McDermott C, Ramsey SD. Completion of radiotherapy for local and regional head and neck cancer in medicare. Arch Otolaryngol Head Neck Surg 2009; 135: 860– 867. 19770417
  35. [37]Lazarev S, Gupta V, Ghiassi-Nejad Z, Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation. Advances Radiat Oncol 2018; 3: 62– 69. PMC5856974 29556582
  36. [38]Thomas K, Martin T, Gao A, Ahn C, Wilhelm H, Schwartz DL. Interruption of head and neck radiotherapy across insured and indigent patient populations. J Oncol Pract 2017; 13: e319– e328. 28267393
  37. [39]Olsen MH, Boje CR, Kjaer TK, Socioeconomic position and stage at diagnosis of head and neck cancer - a nationwide study from DAHANCA. Acta Oncol 2015; 54: 759– 766. 25734503
  38. [40]Boing AF, Antunes JL, de Carvalho MB, How much do smoking and alcohol consumption explain socioeconomic inequalities in head and neck cancer risk? J Epidemiol Commun Health 2011; 65: 709– 714. 20724282
  39. [41]Groome PA, Schulze KM, Keller S, Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol) 2006; 18: 283– 292. 16703745
  40. [42]Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope 2006; 116: 1093– 1106. 16826042
  41. [43]Chandra A, Rick JW, Ore CD, Disparities in health care determine prognosis in newly diagnosed glioblastoma. Neurosurgical Focus 2018; 44: 1– 9. 29852776 PMC6105315
  42. [44]Molina MA, Cheung MC, Perez EA, African American and poor patients have a dramatically worse prognosis for head and neck cancer: An examination of 20,915 patients. Cancer 2008; 113: 2797– 2806. 18839393
  43. [46]Sommers BD, Gawande AA, Baicker K. Health insurance coverage and health - what the recent evidence tells us. N Engl J Med 2017; 377: 586– 593. 28636831
  44. [47]Aday LA, Andersen R. A framework for the study of access to medical care. Health Serv Res 1974; 9: 208– 220. 4436074 PMC1071804
  45. [53]Johnson JE, Nail LM, Lauver D, King KB, Keys H. Reducing the negative impact of radiation therapy on functional status. Cancer 1988; 61: 46– 51. 3334952
  46. [54]White RO, Eden S, Wallston KA, Health communication, self-care, and treatment satisfaction among low-income diabetes patients in a public health setting. Patient Educ Couns 2015; 98: 144– 149. 25468393 PMC4282939
  47. [55]Weyh AM, Lunday L, McClure S. Insurance status, an important predictor of oral cancer surgery outcomes. J Oral Maxillofac Surg 2015; 73: 2049– 2056. 25981863
  48. [56]Terrell JE, Ronis DL, Fowler KE, Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 401– 408. 15096421
  49. [57]Kugaya A, Akechi T, Okuyama T, Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000; 88: 2817– 2823. 10870066
  50. [58]Mick R, Vokes EE, Weichselbaum RR, Panje WR. Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy. Otolaryngol Head Neck Surg 1991; 105: 62– 73. 1909010
  51. [61]Rocque GB, Pisu M, Jackson BE, Resource use and Medicare costs during lay navigation for geriatric patients with cancer. JAMA Oncol 2017; 3: 817– 825. 28125760 PMC5540048
  52. [62]Rocque GB, Williams CP, Jones MI, Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer. Breast Cancer Res Treat 2018; 167: 215– 223. 28900752

Cited by

Sorted by citations

Authors
Wakefield, D. V., Carnell, M., Dove, A. P. H., Edmonston, D. Y., Garner, W. B., Hubler, A., Makepeace, L., Hanson, R., Ozdenerol, E., Chun, S. G., Spencer, S., Pisu, M., Martin, M., Jiang, B., Punglia, R. S., & Schwartz, D. L.
Venue
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Published
2020-07
Volume
107
Issue
4
Pages
815-826
ISSN
0360-3016
Cited by
26
References
2
Language
en
Funders
University of Tennessee Health Science Center

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review